3-(ethoxy(4-methylcyclohexyl)phosphorylamino)-5-phenylthiophene-2-carboxylic acid

ID: ALA4552559

PubChem CID: 68073121

Max Phase: Preclinical

Molecular Formula: C20H26NO4PS

Molecular Weight: 407.47

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOP(=O)(Nc1cc(-c2ccccc2)sc1C(=O)O)C1CCC(C)CC1

Standard InChI:  InChI=1S/C20H26NO4PS/c1-3-25-26(24,16-11-9-14(2)10-12-16)21-17-13-18(27-19(17)20(22)23)15-7-5-4-6-8-15/h4-8,13-14,16H,3,9-12H2,1-2H3,(H,21,24)(H,22,23)

Standard InChI Key:  PERWXTGSISIBKA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   15.2451   -4.2963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8923   -4.7951    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.5680   -4.3352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3372   -3.5486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5211   -3.5284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3370   -4.6101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4819   -5.4155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2504   -5.6911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8747   -5.1623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7252   -4.3546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9568   -4.0828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4587   -4.5269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8678   -3.9623    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.2652   -5.3208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.0594   -2.8541    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4121   -2.1173    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   16.2289   -2.1410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9508   -1.4429    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.6170   -2.8624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4302   -2.8880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8629   -2.1944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4763   -1.4734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6570   -1.4459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6797   -2.2212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5939   -2.1090    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1783   -2.8126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3611   -2.8045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  1  2  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  3  6  1  0
 12 13  1  0
 12 14  2  0
  1 12  1  0
  5 15  1  0
 15 16  1  0
 17 16  1  0
 16 18  2  0
 17 19  1  0
 17 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 21 24  1  0
 16 25  1  0
 25 26  1  0
 26 27  1  0
M  END

Associated Targets(non-human)

Genome polyprotein (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 407.47Molecular Weight (Monoisotopic): 407.1320AlogP: 6.33#Rotatable Bonds: 7
Polar Surface Area: 75.63Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.26CX Basic pKa: CX LogP: 4.35CX LogD: 0.86
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.52Np Likeness Score: -0.51

References

1. Pierra Rouvière C, Amador A, Badaroux E, Convard T, Da Costa D, Dukhan D, Griffe L, Griffon JF, LaColla M, Leroy F, Liuzzi M, Loi AG, McCarville J, Mascia V, Milhau J, Onidi L, Paparin JL, Rahali R, Sais E, Seifer M, Surleraux D, Standring D, Dousson C..  (2016)  Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase.,  26  (18): [PMID:27520942] [10.1016/j.bmcl.2016.01.042]

Source